SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/04/20 Clorox Co/DE 8-K:2,7,9 2/04/20 12:482K DG3/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 30K 2: EX-99.1 Press Release Dated February 4, 2020 of the Clorox HTML 104K Company 3: EX-99.2 Supplemental Information Regarding Financial HTML 60K Results 8: R1 Cover HTML 49K 10: XML IDEA XML File -- Filing Summary XML 12K 9: XML XBRL Instance -- clorox3715881-8k_htm XML 15K 11: EXCEL IDEA Workbook of Financial Reports XLSX 6K 6: EX-101.LAB XBRL Labels -- clx-20200204_lab XML 98K 5: EX-101.PRE XBRL Presentations -- clx-20200204_pre XML 65K 4: EX-101.SCH XBRL Schema -- clx-20200204 XSD 13K 7: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K 12: ZIP XBRL Zipped Folder -- 0001206774-20-000346-xbrl Zip 30K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i February 4, 2020
THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
____________________
i Delaware | i 1-07151 | i 31-0595760 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
i 1221 Broadway, i Oakland,
i California i 94612-1888
(Address
of principal executive offices) (Zip code)
( i 510) i 271-7000
(Registrant's telephone number, including area code)
i Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) |
Name of each exchange on which registered |
i Common Stock - $1.00 par value | i CLX | i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On February 4, 2020, The Clorox Company issued a press release announcing its financial results for its second quarter ended December 31, 2019. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure
Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
See the Exhibit Index below.
Exhibit | Description | |
99.1 | Press Release dated February 4, 2020 of The Clorox Company | |
99.2 | Supplemental information regarding financial results | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE CLOROX COMPANY | ||
Date: February 4, 2020 | By: | /s/ Laura Stein |
Executive Vice President – | ||
General Counsel and Corporate Affairs | ||
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 2/4/20 | 10-Q | ||
12/31/19 | 10-Q, 11-K, 4, SD | |||
List all Filings |